Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Time-in-Range (TIR), a Novel Continuous Glucose Monitoring (CGM) Based Measure, to Improve Risk Stratification of Microvascular Complications in Type 2 Diabetes

NCT05787990 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.

NCT NCT05787990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05787990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Time-in-Range (TIR), a Novel Continuous Glucose Monitoring (CGM) Based Measure, to Improve Risk Stratification of Microvascular Complications in Type 2 Diabetes
Lead sponsor
Singapore General Hospital
Phase
Observational
Overall status
Unknown status
Start date
October 14, 2021
Completion date
December 31, 2024
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes related complications, diabetes; nephropathy (manifestation), diabetes; neuropathy, polyneuropathy (manifestation), diabetes; retinopathy (manifestation), type 2 diabetes